Gong, J., Drobni, Z. D., Alvi, R. M., Murphy, S. P., Sullivan, R. J., Hartmann, S. E., . . . Neilan, T. G. (2021). Immune checkpoint inhibitors for cancer and venous thromboembolic events. European Journal of Cancer, 158, 99. https://doi.org/10.1016/j.ejca.2021.09.010
Chicago Style (17th ed.) CitationGong, Jingyi, et al. "Immune Checkpoint Inhibitors for Cancer and Venous Thromboembolic Events." European Journal of Cancer 158 (2021): 99. https://doi.org/10.1016/j.ejca.2021.09.010.
MLA (9th ed.) CitationGong, Jingyi, et al. "Immune Checkpoint Inhibitors for Cancer and Venous Thromboembolic Events." European Journal of Cancer, vol. 158, 2021, p. 99, https://doi.org/10.1016/j.ejca.2021.09.010.
Warning: These citations may not always be 100% accurate.